Domača stranJ4D • FRA
add
Kenvue Inc
Prejšnji trg. dan.
20,89 €
Dnevni razpon
21,01 € - 22,14 €
Letni razpon
16,08 € - 23,50 €
Tržna kapitalizacija
45,86 mrd. USD
Povprečni obseg
63,00
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
NYSE
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | dec. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 3,66 mrd. | −0,11 % |
Stroški poslovanja | 1,22 mrd. | 0,91 % |
Čisti dohodek | 293,00 mio. | −10,40 % |
Čista dobičkovnost prihodkov | 8,00 | −10,31 % |
Earnings per share | 0,26 | −16,13 % |
EBITDA | 1,01 mrd. | 0,00 % |
Efektivna davčna stopnja | 15,32 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | dec. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 1,07 mrd. | −22,58 % |
Skupna sredstva | 25,60 mrd. | −8,08 % |
Skupne obveznosti | 15,93 mrd. | −4,25 % |
Celoten lastniški kapital | 9,67 mrd. | — |
Shares outstanding | 1,91 mrd. | — |
Razmerje P/B | 4,14 | — |
Donosnost sredstev | 8,17 % | — |
Donosnost kapitala | 11,33 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | dec. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 293,00 mio. | −10,40 % |
Denar iz dejavnosti | 793,00 mio. | −16,53 % |
Denar iz naložb | −132,00 mio. | 50,19 % |
Denar iz financiranja | −587,00 mio. | −53,26 % |
Neto sprememba denarnih sredstev | 13,00 mio. | −95,94 % |
Prost denarni tok | 856,75 mio. | 3,72 % |
Vizitka
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue is the proprietor of well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine.
Kenvue is incorporated under the Delaware General Corporation Law and is headquartered in the Skillman section of Montgomery Township, New Jersey, with plans to relocate its global headquarters to Summit, New Jersey. Before the spin-off, Johnson & Johnson's consumer health division was based in Skillman, even as its pharmaceutical division and medical technologies division, as well as the overall company headquarters, were located in nearby New Brunswick, New Jersey. Wikipedia
Datum ustanovitve
23. feb. 2022
Sedež organizacije
Spletno mesto
Zaposleni
22.000
